• Mashup Score: 0

    Diane Newman engages in a discussion with Howard Goldman on the Uromonitor, a non-invasive urodynamic device designed to measure bladder pressures in a more comfortable, natural setting. This innovative device, developed in partnership with Bright Urology and the Cleveland Clinic, is placed in the bladder and allows patients to move freely without external catheters. The Uromonitor, with its…

    Tweet Tweets with this article
    • Revolutionizing #urodynamics: @Uromonitor's comfortable, real-life #bladder pressure tracking. @DrDianeNewman is joined by Howard Goldman, MD, FACS @CleClinicUro to discuss this innovative device allowing pts to move freely without external catheters > https://t.co/mCXPquXUU1 https://t.co/3ldmRsQVyd

  • Mashup Score: 0

    Studies across a range of solid tumor types, including breast, ovarian, and pancreatic cancers, have demonstrated clinical benefit with poly (ADP-ribose) polymerase (PARP) inhibition, particularly in patients harboring alterations in DNA damage response (DDR) genes such as BRCA1/2. A growing body of evidence also suggests that PARP inhibition may be effective in a broader range of DDR alterations.

    Tweet Tweets with this article
    • What do you consider the most likely explanation for the modest activity of polymerase inhibition in metastatic #urothelial cancer and why? #Bladder #oncology @ASCO #ASCOReadingRoom Read more: https://t.co/VMHmhtHAsU https://t.co/D6TjmlhNOB